These observations are consistent with the window of opportunity hypothesis, which suggests that IL-6 blockade may be more effective in early sJIA, when the disease is characterized by more prominent systemic presentation and less active arthritis (26). This evidence concerns the gene IL6 and arthritic joint disease.